NCT01450098View on ClinicalTrials.gov

A Study of LY2484595 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

LY2484595 Reference Formulation (RF)

Administered orally

DRUG

LY2484595 spray-dried solid dispersion-propyl gallate (SDSD-PG)

Administered orally

Trial Locations (1)

91206

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Glendale

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01450098 - A Study of LY2484595 in Healthy Subjects | Biotech Hunter | Biotech Hunter